As of the latest Form 4 filed Jul 7, 2026.
What Xeris Pharmaceuticals Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 15 most recent filings for XERS.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-07 | Pieper Steven See Remarks | SSale | −27.6K | $8.52 | $235K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-06 | Pieper Steven, See Remarks | SSale | −17.4K | $8.50 | $148K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | McCulloch Kevin See Remarks | SSale | −90.0K | $8.03 | $723K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | KREHER NERISSA Director | AAward | +33.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Hecht Beth See Remarks | SSale | −16.7K | $8.03 | $134K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Brady James Aloysius Director | AAward | +24.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Kong Garheng Director | AAward | +24.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | PERSKY MARLA Director | AAward | +24.2K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | HALKUFF DAWN Director | AAward | +24.2K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | HALKUFF DAWN, Director | SSale | −20.0K | $6.09 | $122K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | AAward | +24.2K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE, Director | SSale | −16.0K | $6.09 | $97.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | JOHNSON JOHN Director | AAward | +24.2K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | JOHNSON JOHN, Director | SSale | −15.0K | $6.09 | $91.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-03 | PERSKY MARLA Director | SSale | −15.5K | $5.90 | $91.4K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also XERS’s full analysis or the market-wide insider trading feed. The tabs above jump to XERS’s other SEC data.
Source: SEC Form 4 filings for XERS, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.